A Pilot Study of FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents
Phase of Trial: Phase II
Latest Information Update: 12 Jul 2019
Price : $35 *
At a glance
- Drugs F-18 fluorothymidine (Primary)
- Indications Solid tumours
- Focus Diagnostic use
- 09 Jul 2019 Planned End Date changed from 1 Jun 2019 to 1 Dec 2019.
- 09 Jul 2019 Planned primary completion date changed from 1 Jun 2019 to 1 Dec 2019.
- 21 Feb 2019 Status changed from recruiting to suspended as referring physician left.